Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: REACTION BIOLOGY CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-08 to 2023-12-07
Current total value of award: $19833.68
Description: PROFILING 10 BTK INHIBITORS VERSUS 20 KINASES